{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:29:21Z","timestamp":1788802161225,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Adenine phosphoribosyltransferase (APRT) deficiency is a rare, hereditary cause of kidney stones and chronic kidney disease (CKD) which is characterized by 2,8-dihydroxyadenine renal parenchymal crystal deposition. The aim of this study was to examine outcomes of kidney transplantation in APRT deficiency patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Included were 13 patients in the APRT Deficiency Registry of the Rare Kidney Stone Consortium, 2 from Westmead Hospital in Sydney, Australia, and 2 from Necker Hospital in Paris, France. The CKD-EPI and CKiD equations were used to calculate glomerular filtration rate estimates. Allograft survival was analyzed employing the Kaplan-Meier method. The Wilcoxon-Mann-Whitney test was used to compare alllograft outcomes according to xanthine oxidoreductase (XOR) inhibitor treatment status at transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Seventeen patients (9 females) received 22 kidney transplants. Age at first transplantation was 47.2 (14.9\u201367.0) years. Ten patients received XOR inhibitor therapy pretransplant (11 allografts), while 8 patients did not receive such treatment before transplantation (11 allografts). Two-year allograft survival was 91% and 55% in the 2 groups, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.16). The median (range) estimated glomerular filtration rate at 2 years posttransplant was 61.3 (24.0\u201390.0) mL\/min\/1.73 m<jats:sup>2<\/jats:sup> when XOR inhibitor therapy was initiated before transplantation, and 16.2 (10.0\u201339.0) mL\/min\/1.73 m<jats:sup>2<\/jats:sup> (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.009) when such treatment was not administered pretransplant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Kidney allograft outcomes are good in APRT deficiency patients beginning XOR inhibitor therapy pretransplant. Delay in such treatment is a major cause of premature graft loss in these patients. Increased awareness among clinicians is imperative, promoting early diagnosis of APRT deficiency and pharmacotherapy initiation before kidney transplantation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003088","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T12:55:04Z","timestamp":1577451304000},"page":"2120-2128","source":"Crossref","is-referenced-by-count":26,"title":["Kidney Transplant Outcomes in Patients With Adenine Phosphoribosyltransferase Deficiency"],"prefix":"10.1097","volume":"104","author":[{"given":"Hrafnhildur Linnet","family":"Runolfsdottir","sequence":"first","affiliation":[{"name":"Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland."},{"name":"Internal Medicine and Rehabilitation Services, Landspitali\u2013The National University Hospital of Iceland, Reykjavik, Iceland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runolfur","family":"Palsson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland."},{"name":"Internal Medicine and Rehabilitation Services, Landspitali\u2013The National University Hospital of Iceland, Reykjavik, Iceland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger M. Sch.","family":"Agustsdottir","sequence":"additional","affiliation":[{"name":"Children\u2019s Medical Center, Landspitali\u2013The National University Hospital of Iceland, Reykjavik, Iceland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olafur S.","family":"Indridason","sequence":"additional","affiliation":[{"name":"Internal Medicine and Rehabilitation Services, Landspitali\u2013The National University Hospital of Iceland, Reykjavik, Iceland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Li","sequence":"additional","affiliation":[{"name":"Centre for Transplant and Renal Research, Westmead Institute for Medical Research, Sydney University, Sydney, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Dao","sequence":"additional","affiliation":[{"name":"Department of Nephrology-Transplantation, Necker Hospital, APHP, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Knebelmann","sequence":"additional","affiliation":[{"name":"Department of Nephrology-Transplantation, Necker Hospital, APHP, Paris, France."},{"name":"Paris Descartes University, Sorbonne Paris Cit\u00e9, Paris, France."},{"name":"D\u00e9partement Biologie cellulaire, INSERM U1151, Institut Necker Enfants Malades, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn S.","family":"Milliner","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidar O.","family":"Edvardsson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland."},{"name":"Children\u2019s Medical Center, Landspitali\u2013The National University Hospital of Iceland, Reykjavik, Iceland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,12,26]]},"reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ndt\/gft248","article-title":"Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease.","volume":"29","author":"Mulay","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"R2-20231002","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1111\/ajt.12926","article-title":"Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure.","volume":"14","author":"Zaidan","year":"2014","journal-title":"Am J Transplant"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.ajkd.2015.10.023","article-title":"Kidney disease in adenine phosphoribosyltransferase deficiency.","volume":"67","author":"Runolfsdottir","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/ajkd.2001.26826","article-title":"Clinical features and genotype of adenine phosphoribosyltransferase deficiency in Iceland.","volume":"38","author":"Edvardsson","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1681\/ASN.2009080808","article-title":"Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency.","volume":"21","author":"Boll\u00e9e","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/ndt\/gfp711","article-title":"Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure.","volume":"25","author":"Nasr","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ekir.2019.04.021","article-title":"Adenine phosphoribosyltransferase deficiency: a potentially reversible cause of CKD.","volume":"4","author":"Li","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1016\/S0272-6386(05)90001-2","article-title":"Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction.","volume":"37","author":"Benedetto","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/ndt\/gfg562","article-title":"Diagnosis of adenine phosphoribosyltransferase deficiency as the underlying cause of renal failure in a renal transplant recipient.","volume":"19","author":"Cassidy","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0022-5347(01)65501-0","article-title":"2,8-dihydroxyadenine stone formation in a renal transplant recipient due to adenine phosphoribosyltransferase deficiency.","volume":"156","author":"de Jong","year":"1996","journal-title":"J Urol"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5414\/CNP61217","article-title":"Four consecutive renal transplantations in a patient with adenine phosphoribosyltransferase deficiency.","volume":"61","author":"Eller","year":"2004","journal-title":"Clin Nephrol"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0272-6386(12)80168-5","article-title":"Chronic renal failure secondary to 2,8-dihydroxyadenine deposition: the first report of recurrence in a kidney transplant.","volume":"24","author":"Gagn\u00e9","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/ki.2012.229","article-title":"2,8-dihydroxyadeninuria disease.","volume":"82","author":"Sharma","year":"2012","journal-title":"Kidney Int"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejim.2017.10.007","article-title":"Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with adenine phosphoribosyltransferase deficiency (APRTd): a clinical trial.","volume":"48","author":"Edvardsson","year":"2018","journal-title":"Eur J Intern Med"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/ctr.12408","article-title":"Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy.","volume":"28","author":"Quaglia","year":"2014","journal-title":"Clin Transplant"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD.","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ahj.2011.06.006","article-title":"Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.","volume":"162","author":"Skali","year":"2011","journal-title":"Am Heart J"},{"key":"R19-20231002","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"R20-20231002","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury.","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/ndt\/13.4.998","article-title":"Recurrence of 2,8-dihydroxyadenine tubulointerstitial lesions in a kidney transplant recipient with a primary presentation of chronic renal failure.","volume":"13","author":"Brown","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1681\/ASN.2013090960","article-title":"Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction.","volume":"25","author":"Kaartinen","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R23-20231002","first-page":"e56","article-title":"Kidney transplantation in a patient with severe adenine phosphoribosyl transferase deficiency: obstacles and pitfalls.","volume":"23","author":"Bertram","year":"2010","journal-title":"Transpl Int"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1177\/1060028013504740","article-title":"Safety and efficacy of allopurinol in chronic kidney disease.","volume":"47","author":"Thurston","year":"2013","journal-title":"Ann Pharmacother"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jchromb.2016.09.018","article-title":"Quantitative UPLC-MS\/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency.","author":"Thorsteinsdottir","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00467-012-2329-z","article-title":"Hereditary causes of kidney stones and chronic kidney disease.","volume":"28","author":"Edvardsson","year":"2013","journal-title":"Pediatr Nephrol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:48:59Z","timestamp":1696225739000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,26]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003088","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,26]]}}}